AGC boosts its biopharmaceutical production capacity

AGC, a world-leading manufacturer of glass, chemicals and high-tech materials, has announced a major expansion of AGC Biologics, a CDMO subsidiary of the company. At AGC Biologics’ Seattle (USA) si...

Rentschler Biopharma buys US manufacturing facility from Shire

Rentschler Biopharma, a leading contract development and manufacturing organization for biopharmaceuticals, has signed an agreement to purchase a manufacturing facility from an affiliate Shire.

Swedish Alliance for ADHD Treatment

Swedish life science company, OnDosis, and global contract development and manufacturing organisation (CDMO), Recipharm, have entered into an agreement for the formulation development of an ADHD treat...

Spanish CDMO ready to meet EU serialisation regulations

Company now able to serialise commercial batches manufactured by them for clients; it can also offer standalone serialisation services as an outsourcing partner. CDMO Idifarma has confirmed it is r...

AGC buys API manufacturer from Boehringer Ingelheim

AGC, a world-leading manufacturer of glass, chemicals and high-tech materials, has announced that it has entered into an agreement with Boehringer Ingelheim to acquire Malgrat Pharma Chemicals.

Voyager Therapeutics entered into collaboration with Brammer Bio and Fujifilm

Voyager Therapeutics announced that it has entered into collaborations with Brammer Bio and Fujifilm Diosynth Biotechnologies to expand manufacturing capabilities.

Cobra Biologics receives a research grant from Innovate UK

Cobra Biologics, an international contract development and manufacturing organization with a focus on advanced therapy medicinal products, has won a £1.5 million shared grant from Innovate UK.

Rentschler Fill Solutions launched a fill and finish facility in Austria

pharma vial
Rentschler Fill Solutions GmbH, a contract development and manufacturing organization and expert in aseptic fill and finish services, officially inaugurated its new facility in Rankweil (Austria).

Piramal Pharma to open its new cGMP kilo lab suite in India

Piramal Pharma Solutions (PPS), a leading Contract Development and Manufacturing Organization, announced the completion of its new cGMP kilo lab suite at its API site in Ennore (Chennai, India).

Cambrex Corporation buys Avista Pharma Solutions

Cambrex, the leading manufacturer of small molecule innovator and generic APIs and finished dosage forms, announced it has entered into a definitive agreement to acquire Avista Pharma Solutions.

Idifarma and Palobiofarma start a new drug development project

Idifarma (Spain), a contract development and manufacturing organization (CDMO), has begun its seventh project with biotechnology company, Palobiofarma (Spain).

Iovance and MaSTherCell entered into manufacturing services agreement

MaSTherCell will manufacture TIL for Iovance’s European late-stage clinical trials in its commercial-ready cGMP manufacturing suites.

Hovione plans to further expand its production capacity

Hovione announces plan to increase production capacity in oral dosage forms. New commercial scale equipment for blending, tableting and coating will complement existing small scale equipment.

FAREVA will use TraceLink serialization solutions for FMD compliance

TraceLink announced that FAREVA has selected TraceLink's serialization solutions to ensure compliance with the EU Falsified Medicines Directive (FMD).

Ajinomoto Althea and OmniChem formed Ajinomoto Bio-Pharma Services

Ajinomoto Althea and OmniChem are integrating their businesses and operations as a unified CDMO, and changing their name to Ajinomoto Bio-Pharma Services.

Piramal Pharma Solutions launches Xcelerate platform

research tube
Piramal Pharma Solutions (PPS), a global leader in Contract Development and Manufacturing Solutions, announced the launch of its Xcelerate Integrated Solutions™ platform.